PrEP Works, But Only When You [Have Access to] Take it: Improving PrEP Access for Young People in Chicago and Philadelphia
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 1
Abstract
The 2012 United States Food and Drug Administration approval of Tenofovir/Emtricitabine for HIV pre-exposure prophylaxis (PrEP) has added a highly effective, safe biomedical option to the HIV prevention toolbox. In the United States, young black and Latino men who have sex with men (MSM) and transgender women are disproportionately affected by HIV risk over the course of their lifetime.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP353872
- DOI 10.23937/2469-567X/1510020
- Views 123
- Downloads 0
Human Immunodeficiency Virus Infections in the Middle East and North Africa: Prevalence, Risk, Prevention and Challenges
Introduction/Objective: The Middle East and North Africa (MENA) has few recorded outputs regarding the prevalence of the human immunodeficiency viral (HIV) infections associated with acquired immune deficiency syndrome (...
Concurrent HIV and Zika Virus Infection, A Problem to be Address in HIV Medicine
HIV infection is a worldwide distributed disease at present. The infection is the most common immunodeficiency disorder and is still the global public health threat. This disease is still non-curable and the continuous r...
Acute Pulmonary Embolism in Dual Dengue Fever and Influenza B Infection
Acute Pulmonary Embolism (PE) is a life-threatening condition and the common cause of death is due to obstruction of main pulmonary vessels by the embolus, resulting in pulmonary hypertension followed by right-sided hear...
Comprehensive Programme to Prevent Cervical Cancer-the Case of Hungary
The overall purpose of a comprehensive cervical cancer prevention programme is to coordinate HPV vaccination (primary prevention) and cervical screening (secondary prevention). Harmonization of the HPV vaccination and po...
Survival among Dually Infected HIV Patients Compared to HIV-1 Mono-Infected Patients Receiving ART in Senegal: A Twelve-Year Cohort Study
In West Africa, HIV-2 single infection (HIV-2s) and HIV-1 + HIV-2 dual infection (HIV-D) remain endemic but their morbidity is progressively decreasing. Among HIV-D infected patients receiving antiretroviral therapy (ART...